Abstract

Cross-desensitization among receptors for peptide chemoattractants have been shown to involve two independent processes, receptor phosphorylation and inhibition of phospholipase C (PLC) activation. Receptors for lipid chemoattractants, i.e. platelet activating factor (PAF) and leukotriene B4, did not inhibit the responses of peptide chemoattractant receptors, suggesting distinct signaling pathways. To examine cross-desensitization between receptors for lipid and peptide chemoattractants, cDNA encoding the PAF receptor (PAFR) was co-expressed into RBL-2H3 cells with cDNAs encoding receptors for either formylated peptides (FR), a product of the fifth component of complement (C5aR) or interleukin-8 A (IL-8RA). PAFR was homologously phosphorylated and desensitized by PAF, and cross-phosphorylated and cross-desensitized by fMet-Leu-Phe, C5a, and IL-8. In contrast, the receptors for peptide chemoattractants were neither cross-phosphorylated nor cross-desensitized by PAF. Staurosporine blocked cross-phosphorylation and cross-desensitization of the PAFR by peptide chemoattractants. Truncation of the cytoplasmic tail of PAFR (mPAFR) abolished its homologous and cross-phosphorylation. mPAFR was also resistant to cross-desensitization by peptide chemoattractants at the level of PLC activation. Interestingly, mPAFR mediated a sustained Ca2+ mobilization in response to PAF and was more active in inducing GTPase activity, phosphoinositide hydrolysis, secretion, and phospholipase D activation than the wild type PAFR. In contrast to PAFR, stimulation of the mPAFR cross-phosphorylated and cross-desensitized responses to IL-8RA. As expected, FR, which is resistant to cross-phosphorylation by C5aR and IL-8RA, was not phosphorylated by mPAFR. However, unlike C5aR and IL-8RA, mPAFR did not inhibit the ability of FR to activate PLC. Blocking Ca2+ influx inhibited mPAFR-mediated sustained Ca2+ response, phospholipase D activation and secretion, but not phosphoinositide hydrolysis and cross-phosphorylation and cross-desensitization of IL-8RA. The data herein suggest that cross-desensitization of PAFR by peptide chemoattractants is solely due to receptor phosphorylation. The PAFR and the peptide chemoattractant receptors do not cross-regulate each other at the level of PLC, suggesting distinct regulatory pathways.

Highlights

  • Cross-desensitization among receptors for peptide chemoattractants have been shown to involve two independent processes, receptor phosphorylation and inhibition of phospholipase C (PLC) activation

  • The data suggest that cross-desensitization of PAF receptor (PAFR) by peptide chemoattractants is solely due to receptor phosphorylation

  • Phosphorylation and Immunoprecipitation of Epitope-tagged Chemoattractant Receptors in RBL-2H3 Cells—RBL-2H3 cells expressing epitope-tagged formylated peptides (FR) and PAFR (FR-PAFR), C5aR and PAFR (C5aR-PAFR), and IL-8RA and PAFR (IL8R-PAFR) were labeled with 32P, treated with different ligands (100 nM platelet activating factor (PAF), 1 ␮M fMLP, 100 nM C5a, or 100 nM IL-8) and cells lysates were immunoprecipitated with 12CA5 antibody, which bind to the epitope tag

Read more

Summary

EVIDENCE FOR INDEPENDENT REGULATORY PATHWAYS*

Chemoattractant-mediated leukocyte functions have been shown to be regulated by a third type of desensitization designated as “class desensitization” [7, 8] This type of desensitization was demonstrated among receptors for peptide chemoattractants (FR, C5aR, and IL-8RA) [9], which utilize the same G protein (Gi␣2) to activate a common pool of phospholipase C (PLC␤2) [10, 11]. The nature of cross-regulation among peptide and lipid chemoattractant receptors was investigated To this end, receptors for PAFR were co-expressed in RBL-2H3 cells with those for FR, C5aR, or IL-8RA to study cross-desensitization among receptor classes.

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call